Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05687344 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intensive Postpartum Antihypertensive Treatment

Study acronym: IPAT
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date changed from estimate of Mar 2026 to Mar 31, 2026 Completion date: Mar 2026 to Aug 30, 2026v8 Show 1 more changeShow less
    • Completion date: Mar 2026 to Aug 30, 2026
  2. Re-verified, no change to tracked fieldsv7
  3. Trial status: Recruiting to Active, Not Recruiting Site details revisedv6 Show 1 more changeShow less
    • Site details revised
  4. Study description revisedv5 See this version in full on ClinicalTrials.gov ↗
  5. Interventions: NIFEdipine ER (Drug) to Nifedipine ER (Drug)v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Aug 14, 2023 to Sep 1, 2023v3 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 14, 2023 to Sep 1, 2023
  2. Start date: Mar 2023 to Aug 14, 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.
Trial Details
NCT Number NCT05687344
Lead Sponsor Medical College of Wisconsin
Conditions Hypertensive Disorder of Pregnancy
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov